Search

everythinglearnresearchcommunity

for

Search:↓

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

Poly(ADP-ribose) synthesis is linked to skin cell differentiation.

Single-cell encapsulation shows promise for medical use but faces production challenges.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

AD-derived keratinocytes effectively mimic inflammation in atopic dermatitis.

PBM helps improve cell survival in 3D tissue engineering.

Understanding how our bodies interact with mosquito-borne viruses is crucial because there are few treatments and vaccines.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Recent dermatological research highlights include new virus discoveries, genetic links to skin conditions, and insights into skin healing and pigmentation.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Targeting specific T cells may help treat alopecia areata.

Low-level laser therapy, now called photobiomodulation, is recognized for its broad medical applications and scientific backing.

Leukocyte recruitment is complex but crucial for resolving inflammation and developing effective therapies.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

Activin increases skin tumor formation, skin Tregs help hair growth, lymph-node removal doesn't improve melanoma survival, cells can revert to stem cells in wound healing, and skin bacteria produce peptides that may treat infections.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

Immune cells and cytokines significantly affect pathological scar development.

Personalized treatment considering atopic status and cytokine profiles may help in managing pediatric alopecia areata.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

The meeting highlighted major advances in skin research, including new findings on skin microbes, genetic links to skin diseases, and improved treatments for various conditions.

Hair helps prevent scalp skin cancer by supporting immune protection.